Mauricio Jalife Bucay, MD

HS Assoc Clinical Professor

Mauricio Jalife is an academic hospitalist and clinician educator in the Department of Hospital Medicine at UCSF since Feb 2020
Compassionate, patient-focused physician with Board Certification in Internal Medicine. Experience in hospital and clinical settings across varied specialties and a background working with diverse and low-income populations. Additional experience as a clinical researcher and assistant professor for medical schools.

Education
Internal Medicine Resident, 06/2016 - Internal medicine, Albert Einstein Medical Center
MD, 03/2010 - Medical Doctor, Universidad Anahuac de la Ciudad de Mexico
Honors and Awards
  • Outstanding performance in the standardized professional exam (CENEVAL), Universidad Anahuac de la Ciudad de Mexico, 2010
Publications
  1. Koshkelashvili N, Jalife Bucay M, Goykhman I, Pressman GS. Aortic root and valve proportions: an example of the golden ratio? Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2019. PMID: 31315350


  2. Rubio M, Dias A, Koshkelashvili N, Codolosa JN, Jalife-Bucay M, Rodriguez-Ziccardi M, Amanullah AM. Transient Ischemic Dilation Ratio in Regadenoson, Single Isotope Gated Single-photon Emission Computed Tomography Myocardial Perfusion Imaging. World journal of nuclear medicine 2017. PMID: 28670181


  3. Thakar S, Koshkelashvili N, Bucay MJ, Lichstein E, Saqid A, Pressman GS, Figueredo VM. Electrocardiographic changes in patients = 100 years of age. International journal of cardiology 2016. PMID: 26946042


  4. Faverio P, Arango A, Anzueto A, Mortensen E, Waterer G, Wunderink R, Houlihan T, Ezekiel C, Jalife M, Restrepo M. Azithromycin-Related Cardiovascular Events and Deaths in Severe Septic Patients Azithromycin-Related Cardiovascular Events and Deaths in Severe Septic Patients 2013. PMID:


  5. Maselli D, Faverio P, Arango A, Fernandez J, Aliberti S, Lonni S, Jalife M, Ezekiel C, Restrepo M. Idiopathic Bronchiectasis Less Common Than Predicted: Quality Improvement Project Idiopathic Bronchiectasis Less Common Than Predicted: Quality Improvement Project 2013. PMID:


  6. Randall C, Jalife M, Rellas J, Toboada C, Gossen G, Havranek R, Zurita F, Stump D, Fincke C, Ford J, Jamie J.. Rifaximin is Efficacious in the Treatment of Small Intestine Bacterial Overgrowth Rifaximin is Efficacious in the Treatment of Small Intestine Bacterial Overgrowth 2009. PMID:


  7. Randall C, Jalife M, Rellas J, Toboada C, Gossen G, Havranek R, Zurita F, Stump D, Fincke C, Ford J, Jamie J. The Efficacy and Tolerability of Neomycin in the Treatment of Small Intestine Bacterial Overgrowth The Efficacy and Tolerability of Neomycin in the Treatment of Small Intestine Bacterial Overgrowth 2009. PMID: